Jacobs Levy Equity Management, Inc Nautilus Biotechnology, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 225,098 shares of NAUT stock, worth $164,321. This represents 0.0% of its overall portfolio holdings.
Number of Shares
225,098Holding current value
$164,321% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NAUT
# of Institutions
91Shares Held
63.9MCall Options Held
28.5KPut Options Held
6K-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$11.9 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$9.19 Million0.45% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$5.24 Million0.19% of portfolio
-
Madrona Venture Group, LLC6.02MShares$4.4 Million18.2% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$2.79 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $91M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...